|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Sell||Strong Sell||Strong Sell||Strong Sell||Neutral|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Neutral|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Down||1M||Current|
|Engulfing Bearish||1M||1||Nov 17|
|Engulfing Bearish||15||1||Dec 14, 2017 13:30|
|Evening Doji Star||15||1||Dec 14, 2017 13:30|
|Punjab National Bank||169.60||170.65||166.15||+1.80||+1.07%||9.32M||13:51:30|
|Oil & Natural Gas||184.15||186.70||182.40||+0.25||+0.14%||3.81M||13:51:30|
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.Read More
Add a Comment
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.